Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (990) Neurology and Neurosciences (402) Clinical Cancer Research (261) Prostate Cancer (85) Chemotherapy and Side Effects Management (153) Urology (69) Clinical Trials and Protocols in Perioperative Medicine (38)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/97886, first published .
Doctor reassures concerned senior man about joint pain in clinic

Neoadjuvant Apalutamide With or Without Abiraterone Acetate Plus Prednisone and Gonadotropin-Releasing Hormone Agonist Prior to Nerve-Sparing Radical Prostatectomy in High-Risk Prostate Cancer: Protocol for a Randomized Phase 2 Trial

Neoadjuvant Apalutamide With or Without Abiraterone Acetate Plus Prednisone and Gonadotropin-Releasing Hormone Agonist Prior to Nerve-Sparing Radical Prostatectomy in High-Risk Prostate Cancer: Protocol for a Randomized Phase 2 Trial

Authors of this article:

Anthony Y Zhang1 Author Orcid Image ;   Mark N Stein2 Author Orcid Image ;   Saum Ghodoussipour3 Author Orcid Image ;   Isaac Y Kim1 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Anthony Y Zhang   1 , BS ;   Mark N Stein   2 , MD ;   Saum Ghodoussipour   3 , MD ;   Isaac Y Kim   1 , MBA, MD, PhD

1 Department of Urology, School of Medicine, Yale University, New Haven, CT, United States

2 Division of Medical Oncology, College of Physicians and Surgeons, Columbia University, New York, NY, United States

3 Division of Urology, Department of Surgery, Robert Wood Johnson Medical School, New Brunswick, NJ, United States

Corresponding Author:

  • Isaac Y Kim, MBA, MD, PhD
  • Department of Urology
  • School of Medicine, Yale University
  • 333 Cedar Street
  • New Haven, CT 06510
  • United States
  • Phone: 1 877-925-3637
  • Email: isaac.kim@yale.edu